; (3) standardized methods such as those that are available in textbooks and peer-reviewed publications; or (4) methods in which performance specifications are not provided by the manufacturer of test systems or components. (e) Public meeting Not later than 90 days after the date of enactment of this Act, the Administrator of the Centers for Medicare & Medicaid Services shall hold a public meeting to solicit recommendations on updating the regulations under section 353 of the Public Health Service Act ( 42 U.S.C. 263a ). (f) Report to Congress Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, the following: (1) Recommendations to update section 353 of the Public Health Service Act ( 42 U.S.C. 263a ) and the regulations promulgated under such section, taking into consideration input and recommendations from the Clinical Laboratory Improvement Advisory Committee, to reflect the current state of the field of clinical laboratory testing. (2) An assessment of the availability and utilization of laboratory-developed testing procedures during the 2020 COVID–19 pandemic response that includes— (A) validation criteria and process, and average length of time from validation to achieving emergency use authorization under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) before, and after, February 29, 2020; (B) the number of patients and samples tested by laboratories using such testing procedures; and (C) recommendations to ensure that during future infectious disease outbreaks, the public health system and clinical laboratories do not encounter delays to testing.